A Phase III Multicenter, Single Blind, Randomized, Comparative and add-on Clinical Trial, in Three Parallel Groups, to Evaluate Efficacy and ... View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2007-2009

ABSTRACT

Anal fistula is defined as an abnormal communication between the anal canal and the perianal skin. Adipose-derived stem cells are a new therapy for the closure of these fistulas. This study will test the safety and efficacy of ASCs (adipose stem cells) in the treatment of patients without Crohn´s disease. Detailed Description Perianal fistula accounts for 10% to 30% of coloproctological surgical procedures. Currently accepted conventional treatment is surgery intended to treat the tracts using different technical options. This surgery usually has a highly bothersome postoperative period and may involve two major complications: anal incontinence and recurrence. The biological properties of stem cells derived from adult tissues make them adequate candidates for the treatment of diseases in which tissues are damaged or the healing process is altered. This study will compare the efficacy of ASCs versus ASCs plus Fibrin adhesive versus Fibrin adhesive alone for closure of complex perianal fistulas not associated to Inflammatory Bowel Disease. Fistula closure is defined as absence of suppuration and re-epithelization of the external opening in the clinical evaluation and absence of collections >2 cm directly related to the fistula tract treated, as measured by MRI More... »

URL

https://clinicaltrials.gov/show/NCT00475410

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3053", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "Anal fistula is defined as an abnormal communication between the anal canal and the perianal skin. Adipose-derived stem cells are a new therapy for the closure of these fistulas. This study will test the safety and efficacy of ASCs (adipose stem cells) in the treatment of patients without Crohn\u00b4s disease.\n\nDetailed Description\nPerianal fistula accounts for 10% to 30% of coloproctological surgical procedures. Currently accepted conventional treatment is surgery intended to treat the tracts using different technical options. This surgery usually has a highly bothersome postoperative period and may involve two major complications: anal incontinence and recurrence. The biological properties of stem cells derived from adult tissues make them adequate candidates for the treatment of diseases in which tissues are damaged or the healing process is altered. This study will compare the efficacy of ASCs versus ASCs plus Fibrin adhesive versus Fibrin adhesive alone for closure of complex perianal fistulas not associated to Inflammatory Bowel Disease. Fistula closure is defined as absence of suppuration and re-epithelization of the external opening in the clinical evaluation and absence of collections >2 cm directly related to the fistula tract treated, as measured by MRI", 
    "endDate": "2009-08-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT00475410", 
    "keywords": [
      "Phase III", 
      "single-blind", 
      "clinical trial", 
      "parallel group", 
      "efficacy", 
      "therapy", 
      "autologous stem cell", 
      "complex", 
      "in-patient", 
      "inflammatory bowel disease", 
      "fistula", 
      "communication", 
      "anal", 
      "skin", 
      "adipose-derived stem cells", 
      "closure", 
      "safety", 
      "ASC", 
      "adipose stem cell", 
      "patient", 
      "disease", 
      "surgical procedure", 
      "conventional treatment", 
      "General Surgery", 
      "tract", 
      "option", 
      "postoperative period", 
      "major complication", 
      "incontinence", 
      "Recurrence", 
      "biological property", 
      "stem cell", 
      "adult tissue", 
      "tissue", 
      "healing process", 
      "fibrin", 
      "absence", 
      "re", 
      "opening", 
      "clinical evaluation", 
      "collection", 
      "cm", 
      "MRI"
    ], 
    "name": "A Phase III Multicenter, Single Blind, Randomized, Comparative and add-on Clinical Trial, in Three Parallel Groups, to Evaluate Efficacy and Safety of a New Therapy With Adipose-derived Autologous Stem Cells for the Treatment of Complex Perianal Fistulas in Patients Without Inflammatory Bowel Disease", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT00475410"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:22", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00004.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.144756.5", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.413524.5", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.106023.6", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.81821.32", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.410526.4", 
        "type": "Organization"
      }
    ], 
    "startDate": "2007-02-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "https://doi.org/10.1007/s10350-005-0052-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024310014"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00384-003-0490-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031403617", 
          "https://doi.org/10.1007/s00384-003-0490-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/dcr.0b013e318255364a", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043218882"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT00475410"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT00475410'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT00475410'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT00475410'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT00475410'


 

This table displays all metadata directly associated to this object as RDF triples.

80 TRIPLES      16 PREDICATES      65 URIs      52 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT00475410 schema:about anzsrc-for:3053
2 schema:description Anal fistula is defined as an abnormal communication between the anal canal and the perianal skin. Adipose-derived stem cells are a new therapy for the closure of these fistulas. This study will test the safety and efficacy of ASCs (adipose stem cells) in the treatment of patients without Crohn´s disease. Detailed Description Perianal fistula accounts for 10% to 30% of coloproctological surgical procedures. Currently accepted conventional treatment is surgery intended to treat the tracts using different technical options. This surgery usually has a highly bothersome postoperative period and may involve two major complications: anal incontinence and recurrence. The biological properties of stem cells derived from adult tissues make them adequate candidates for the treatment of diseases in which tissues are damaged or the healing process is altered. This study will compare the efficacy of ASCs versus ASCs plus Fibrin adhesive versus Fibrin adhesive alone for closure of complex perianal fistulas not associated to Inflammatory Bowel Disease. Fistula closure is defined as absence of suppuration and re-epithelization of the external opening in the clinical evaluation and absence of collections >2 cm directly related to the fistula tract treated, as measured by MRI
3 schema:endDate 2009-08-01T00:00:00Z
4 schema:keywords ASC
5 General Surgery
6 MRI
7 Phase III
8 Recurrence
9 absence
10 adipose stem cell
11 adipose-derived stem cells
12 adult tissue
13 anal
14 autologous stem cell
15 biological property
16 clinical evaluation
17 clinical trial
18 closure
19 cm
20 collection
21 communication
22 complex
23 conventional treatment
24 disease
25 efficacy
26 fibrin
27 fistula
28 healing process
29 in-patient
30 incontinence
31 inflammatory bowel disease
32 major complication
33 opening
34 option
35 parallel group
36 patient
37 postoperative period
38 re
39 safety
40 single-blind
41 skin
42 stem cell
43 surgical procedure
44 therapy
45 tissue
46 tract
47 schema:name A Phase III Multicenter, Single Blind, Randomized, Comparative and add-on Clinical Trial, in Three Parallel Groups, to Evaluate Efficacy and Safety of a New Therapy With Adipose-derived Autologous Stem Cells for the Treatment of Complex Perianal Fistulas in Patients Without Inflammatory Bowel Disease
48 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT00475410
49 schema:sdDatePublished 2019-03-07T15:22
50 schema:sdLicense https://scigraph.springernature.com/explorer/license/
51 schema:sdPublisher N8c536670782147ec950a600b21c7ab13
52 schema:sponsor https://www.grid.ac/institutes/grid.106023.6
53 https://www.grid.ac/institutes/grid.144756.5
54 https://www.grid.ac/institutes/grid.410526.4
55 https://www.grid.ac/institutes/grid.413524.5
56 https://www.grid.ac/institutes/grid.81821.32
57 schema:startDate 2007-02-01T00:00:00Z
58 schema:subjectOf sg:pub.10.1007/s00384-003-0490-3
59 https://doi.org/10.1007/s10350-005-0052-6
60 https://doi.org/10.1097/dcr.0b013e318255364a
61 schema:url https://clinicaltrials.gov/show/NCT00475410
62 sgo:license sg:explorer/license/
63 sgo:sdDataset clinical_trials
64 rdf:type schema:MedicalStudy
65 N8c536670782147ec950a600b21c7ab13 schema:name Springer Nature - SN SciGraph project
66 rdf:type schema:Organization
67 anzsrc-for:3053 schema:inDefinedTermSet anzsrc-for:
68 rdf:type schema:DefinedTerm
69 sg:pub.10.1007/s00384-003-0490-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031403617
70 https://doi.org/10.1007/s00384-003-0490-3
71 rdf:type schema:CreativeWork
72 https://doi.org/10.1007/s10350-005-0052-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024310014
73 rdf:type schema:CreativeWork
74 https://doi.org/10.1097/dcr.0b013e318255364a schema:sameAs https://app.dimensions.ai/details/publication/pub.1043218882
75 rdf:type schema:CreativeWork
76 https://www.grid.ac/institutes/grid.106023.6 schema:Organization
77 https://www.grid.ac/institutes/grid.144756.5 schema:Organization
78 https://www.grid.ac/institutes/grid.410526.4 schema:Organization
79 https://www.grid.ac/institutes/grid.413524.5 schema:Organization
80 https://www.grid.ac/institutes/grid.81821.32 schema:Organization
 




Preview window. Press ESC to close (or click here)


...